Effect of an Educational Intervention in Women With Breast Cancer (EDU-INT-BC)
EDU-INT-BC
1 other identifier
interventional
65
1 country
1
Brief Summary
This study aims to evaluate the effect of an educational intervention on sexual function and therapeutic adherence among women with breast cancer followed in the medical oncology department of Ibn Tofail Hospital, affiliated with Mohammed VI University Hospital Center in Marrakech. Participants will receive a structured therapeutic education program focusing on breast cancer, available treatments and their potential side effects, as well as treatment adherence and its prognostic significance. Educational sessions will be complemented by patient follow-up to reinforce key messages and support adherence. The study will assess changes in sexual function and therapeutic adherence before and after the educational intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 17, 2026
CompletedFirst Posted
Study publicly available on registry
January 26, 2026
CompletedStudy Start
First participant enrolled
January 26, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedMarch 3, 2026
January 1, 2026
2 months
January 17, 2026
February 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Sexual Function Score (FSFI)
Sexual function will be assessed using the Female Sexual Function Index (FSFI), a validated questionnaire with a total score ranging from 2 to 36, where higher scores indicate better sexual function. The primary outcome will be the change in the total FSFI score between baseline and two months after the educational intervention.
Baseline and 2 months after the intervention
Secondary Outcomes (1)
Change in Therapeutic Adherence Score (ARMS-12)
Baseline and 2 months after the intervention
Study Arms (1)
Educational Intervention Arm
EXPERIMENTALParticipants assigned to this arm will receive a structured educational intervention focusing on breast cancer, treatment-related side effects, sexual health, and therapeutic adherence. The intervention consists of two educational sessions of two hours each, followed by follow-up support via WhatsApp. Outcomes will be assessed before the intervention and two months after its implementation.
Interventions
This intervention will consist of a structured therapeutic education program designed for women with breast cancer. The program will focus on disease-related information, treatment modalities and their associated side effects, sexual function, and strategies to improve therapeutic adherence. The intervention will include two face-to-face educational sessions, each lasting two hours, delivered by a midwife enrolled in the final semester of a Master's program in advanced practices in oncology and Palliatives Cares, followed by supportive follow-up via WhatsApp to reinforce key messages and address participants' concerns. The educational content will be adapted to participants' needs and health literacy levels. Outcomes related to sexual function and treatment adherence will be assessed before the intervention and two months after its implementation.
Eligibility Criteria
You may qualify if:
- Women aged 18 years and older.
- Diagnosed with breast cancer.
- Receiving oral anticancer treatment.
- Willing to participate in the study.
- Able to attend the educational sessions.
- Having access to a mobile phone (smartphone).
You may not qualify if:
- Women with communication disorders.
- Women with severe psychiatric disorders that will interfere with participation in the educational intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical Oncology Department, Ibn Tofail Hospital, Mohammed VI University Hospital Center
Marrakesh, Marrakech-Safi, Morocco
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Master's student in advanced practices in oncology and palliative care
Study Record Dates
First Submitted
January 17, 2026
First Posted
January 26, 2026
Study Start
January 26, 2026
Primary Completion
April 1, 2026
Study Completion
April 1, 2026
Last Updated
March 3, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share